Life Healthcare Group Holdings Limited, together with its subsidiaries, operates private hospitals in South Africa, Poland, the United Kingdom, rest of Europe, and Internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||R23.25|
|52 Week High||R15.00|
|52 Week Low||R28.20|
|1 Month Change||-6.44%|
|3 Month Change||-0.85%|
|1 Year Change||45.13%|
|3 Year Change||-3.61%|
|5 Year Change||-36.80%|
|Change since IPO||72.22%|
Recent News & Updates
Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
|LHC||ZA Healthcare||ZA Market|
Return vs Industry: LHC exceeded the ZA Healthcare industry which returned 28.9% over the past year.
Return vs Market: LHC exceeded the ZA Market which returned 21.3% over the past year.
Stable Share Price: LHC is less volatile than 75% of ZA stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: LHC's weekly volatility (3%) has been stable over the past year.
About the Company
Life Healthcare Group Holdings Limited, together with its subsidiaries, operates private hospitals in South Africa, Poland, the United Kingdom, rest of Europe, and Internationally. It operates through two segments, Hospitals and Complementary Services; and Healthcare Services. The company provides range of acute hospitals and complementary services; Life Esidimeni services, such as chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, primary healthcare and substance abuse recovery programs; and life employee health solutions, including on-site occupational and primary healthcare services and employee wellness programs.
Life Healthcare Group Holdings Fundamentals Summary
|LHC fundamental statistics|
Is LHC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|LHC income statement (TTM)|
|Cost of Revenue||R18.88b|
Last Reported Earnings
Mar 31, 2021
Next Earnings Date
Nov 18, 2021
|Earnings per share (EPS)||-0.12|
|Net Profit Margin||-0.65%|
How did LHC perform over the long term?See historical performance and comparison
Is Life Healthcare Group Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: LHC (ZAR23.25) is trading below our estimate of fair value (ZAR31.38)
Significantly Below Fair Value: LHC is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: LHC is unprofitable, so we can't compare its PE Ratio to the African Healthcare industry average.
PE vs Market: LHC is unprofitable, so we can't compare its PE Ratio to the ZA market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate LHC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: LHC is good value based on its PB Ratio (2x) compared to the XF Healthcare industry average (2.7x).
How is Life Healthcare Group Holdings forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LHC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (8.8%).
Earnings vs Market: LHC is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: LHC's is expected to become profitable in the next 3 years.
Revenue vs Market: LHC's revenue (8.4% per year) is forecast to grow faster than the ZA market (6.1% per year).
High Growth Revenue: LHC's revenue (8.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LHC's Return on Equity is forecast to be low in 3 years time (13.2%).
How has Life Healthcare Group Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: LHC is currently unprofitable.
Growing Profit Margin: LHC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: LHC is unprofitable, and losses have increased over the past 5 years at a rate of 7.2% per year.
Accelerating Growth: Unable to compare LHC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LHC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (4.5%).
Return on Equity
High ROE: LHC has a negative Return on Equity (-0.88%), as it is currently unprofitable.
How is Life Healthcare Group Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: LHC's short term assets (ZAR7.0B) do not cover its short term liabilities (ZAR9.1B).
Long Term Liabilities: LHC's short term assets (ZAR7.0B) do not cover its long term liabilities (ZAR11.2B).
Debt to Equity History and Analysis
Debt Level: LHC's debt to equity ratio (74.6%) is considered high.
Reducing Debt: LHC's debt to equity ratio has reduced from 101.4% to 74.6% over the past 5 years.
Debt Coverage: LHC's debt is well covered by operating cash flow (30.3%).
Interest Coverage: LHC's interest payments on its debt are not well covered by EBIT (2.8x coverage).
What is Life Healthcare Group Holdings's current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate LHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate LHC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if LHC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LHC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: LHC is not paying a notable dividend for the ZA market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of LHC's dividend in 3 years as they are not forecast to pay a notable one for the ZA market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Peter Wharton-Hood (55 yo)
Mr. Peter G. Wharton-Hood, (BCom (Hons) (Wits), CA(SA), AMP (Harvard)), serves as the Group Chief Executive Officer at Life Healthcare Group Holdings since September 1, 2020 and also serves as its Executiv...
CEO Compensation Analysis
Compensation vs Market: Peter's total compensation ($USD528.57K) is below average for companies of similar size in the ZA market ($USD922.82K).
Compensation vs Earnings: Insufficient data to compare Peter's compensation with company performance.
Experienced Management: LHC's management team is considered experienced (2.6 years average tenure).
Experienced Board: LHC's board of directors are considered experienced (7.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Life Healthcare Group Holdings Limited's employee growth, exchange listings and data sources
- Name: Life Healthcare Group Holdings Limited
- Ticker: LHC
- Exchange: JSE
- Founded: 1983
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: R33.799b
- Shares outstanding: 1.45b
- Website: https://www.lifehealthcare.co.za
Number of Employees
- Life Healthcare Group Holdings Limited
- Oxford Parks
- Building 2
- South Africa
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/17 17:05|
|End of Day Share Price||2021/10/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.